Stay updated on Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page.

Latest updates to the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page
- Check3 days agoChange DetectedNew sections to guide users have been added ('No longer looking for participants', 'How to Read a Study Record', 'Common Questions', 'How to Join a Study') and a new revision label v3.6.0 appears. The heading 'Intervention / Treatment' was replaced by 'Intervention/Treatment', and the prior revision label v3.5.5 was removed.SummaryDifference0.2%

- Check10 days agoChange DetectedResults have been posted for the study, and the page now notes 127 locations. The update also introduces detailed outcome definitions for progression-free survival (PFS) and overall survival (OS), along with associated measurement timelines and related data elements.SummaryDifference2%

- Check17 days agoChange DetectedThe study's publication citation for the Phase 3 SKYSCRAPER-06 trial was updated to include the online identifier e260818 and the DOI, replacing the previous entry that did not include the identifier.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now lists Revision: v3.5.4, replacing the previous v3.5.3, indicating an update to the page's revision rather than a modification to the clinical trial details.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page now displays 'Results Submitted' where it previously showed 'No Results Posted,' indicating that trial results are in the submission/availability process. This marks a status update in the study record reflecting that results data have been prepared for posting.SummaryDifference0.0%

- Check46 days agoChange DetectedA Publications section has been added, including the Phase 3 SKYSCRAPER-06 article citation (JAMA Oncol. 2026) with DOI and author list, plus a note that publications are auto-filled from PubMed.SummaryDifference0.1%

Stay in the know with updates to Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page.